The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Ependymoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Ependymoma (Oncology) - Drugs in Development, 2021 SUMMARY Ependymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma pipeline landscape. The report provides comprehensi...
April 2021
55 pages
Epidermal Growth Factor (EGF) - Drugs in Development, 2021
US$ 3,000.00
Epidermal Growth Factor (EGF) - Drugs in Development, 2021 SUMMARY Epidermal Growth Factor (EGF) - Drugs in Development, 2021 provides in depth analysis on Epidermal Growth Factor (EGF) targeted pipel...
April 2021
35 pages
Fever (Other Diseases) - Drugs in Development, 2021
US$ 2,000.00
Fever (Other Diseases) - Drugs in Development, 2021 SUMMARY Fever (Other Diseases) - Drugs in Development, 2021 provides an overview of the Fever pipeline landscape. The report provides comprehensive...
April 2021
35 pages
Fibrosis (Musculoskeletal) - Drugs in Development, 2021
US$ 2,500.00
Fibrosis (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Fibrosis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Fibrosis pipeline landscape. The report provides com...
April 2021
250 pages
Follicular Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Follicular Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Follicular Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Follicular Lymphoma pipeline landscape. The...
April 2021
375 pages
Food Allergy (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Food Allergy (Immunology) - Drugs in Development, 2021 SUMMARY Food Allergy (Immunology) - Drugs in Development, 2021 provides an overview of the Food Allergy pipeline landscape. The report provides c...
April 2021
60 pages